Astrovirus (HAstV) is an RNA virus primarily responsible for affecting the intestinal system. Astrovirus infection is more common in children 1 to 10 years old and rarely affects adults. Astroviruses have a single-stranded RNA genome and can survive for a long time.
The virus is common in cold winters as they exist in temperatures below 20 degrees Celsius. Astrovirus infection can cause severe stomach flu, commonly known as gastroenteritis. In addition, astrovirus infection can also cause severe cases of diarrhea and vomiting.
Astrovirus infection is one of the most common causes of acute diarrhea in children. Infectious astroviruses can cause more severe disease in children with cancer and compromised immune systems. Astrovirus infection is considered an important cause of viral gastroenteritis.
To stay “ahead” of your competitors, request samples @ https://www.persistencemarketresearch.com/samples/23053
Astroviruses are contagious infections that spread from person to person via the fecal-oral route. Currently, there is no specific treatment or vaccine for astrovirus infection. But a variety of therapies are used to treat astrovirus infections.
Growing adoption of advanced molecular techniques and rising incidence of acute diarrhea in children is expected to increase the demand for astrovirus infection treatment market. Increasing government funding in the healthcare sector and growing trend in the production of novel drugs by pharmaceutical companies are further factors driving the growth of the global astrovirus infection treatment market.
However, the lack of absolute treatment and limited efficacy of available drugs in the market is expected to hinder the revenue growth of the global astrovirus infection treatment market over the forecast period. Furthermore, lack of awareness of novel diagnostic tests is inhibiting the growth of the astrovirus infection treatment market.
Get a custom scope consulting specialist to suit your needs – sales@persistencemarketresearch.com
segmentation
The Global Market for Astrovirus Infection Treatment is segmented on the basis of Astrovirus (HAstV) Type Treatment, Application, End User, and Geography:
| Astrovirus types: |
|
| Therapeutic therapy |
|
| end user |
|
On the basis of geography, the global astrovirus infection treatment market is segmented into six key regions, viz. North America, Latin America, Europe, Asia Pacific (excluding China), China, and Middle East & Africa. North America and Europe are expected to be the major markets for the global astrovirus infection treatment market.
The increasing number of patients with abdominal pain and astrovirus infection is expected to increase the demand for astrovirus infection treatment therapies in these regions. APEC and China are expected to follow in terms of demand for treatment of astrovirus infections.
The Latin America and MEA astrovirus infection treatment market is also expected to witness above-average growth over the forecast period. The lack of population-based studies in developing countries is a major challenge in evaluating the treatment of astrovirus infection in these countries.
Some of the key players in the global astrovirus infection treatment market include Johnson & Johnson Services, Teva Pharmaceutical Industries, Inc., Pfizer, AstraZeneca, Novartis, Eli Lilly, Bristol-Myers Squibb, and others.
Book now for exclusive analyst support @ https://www.persistencemarketresearch.com/checkout/23053
The report covers exhaustive analysis of:
- Astrovirus Infection Treatment Market Segmentation
- Astrovirus Infection Treatment Market Dynamics
- Historical actual market size, 2013 – 2017
- Astrovirus Infection Treatment Market Size and Forecast 2017-2026
- Astrovirus Infection Therapeutics Market Current Trends/Problems/Challenges
- Competition and companies involved
- Astrovirus Infection Therapeutics Market Drivers and Restraints
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – www.persistencemarketresearch.com